Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis symptom recrudescence at the end of the natalizumab dosing cycle.
Expression of IL-33 and its epigenetic regulation in Multiple Sclerosis.
High-dose cyclophosphamide in multiple sclerosis patients undergoing autologous stem cell transplantation.
MARGA: Multispectral Adaptive Region Growing Algorithm for brain extraction on axial MRI.
Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS] (RECYCLINE)
The antiepileptic drug valproic acid restores T cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis.
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
Innovation at RUSH
Incidence of multiple sclerosis in Northern Lisbon, Portugal: 1998¿2007.
Does glatiramer acetate provoke hepatitis in multiple sclerosis?
Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosis.
MYRAC Rx
Ginseng in the Treatment of Fatigue in Multiple Sclerosis: A Randomized Placebo-Controlled Double-Blind Pilot Study.
Slowing of brain atrophy and reductions in new multiple sclerosis lesions sustained at three years in patients treated with Genzyme's LemtradaTM
Efficacy of idebenone for respiratory failure in a patient with Leigh syndrome: a long-term follow-up study.
Forsythiaside A Exhibits Anti-inflammatory Effects in LPS-Stimulated BV2 Microglia Cells Through Activation of Nrf2/HO-1 Signaling Pathway.
Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination.
Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison.
Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients.
Neuromyelitis optica with very late onset.
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.
CD46: The 'multitasker' of complement proteins.
Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory Diseases
A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C.
Epidermal pigmentation in the human lineage is an adaptation to ultraviolet radiation.

Pages